Clinical Trials Directory

Trials / Completed

CompletedNCT03002584

International Psychometric Validation Study of the Intestinal Gas Questionnaire (IGQ)

Status
Completed
Phase
Study type
Observational
Enrollment
300 (actual)
Sponsor
University Paris 7 - Denis Diderot · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Objective: To confirm the psychometrics properties of the Intestinal Gas Questionnaire (IGQ) in subjects with Irritable Bowel Syndrome (IBS) diagnosis and General population both complaining of Gas-Related Symptoms (GRS). IGQ has been developed previously simultaneously in UK English, French and Spanish through qualitative research with subject interviews. The conceptual framework of the IGQ assesses both GRS and their impact on daily life. Similar concepts were identified for both subjects with IBS diagnosis and general population and complaining of gas-related symptoms. The IGQ consists of a 24-hour recall symptom diary assessing 7 gas-related symptoms (17 items) and a 7-day recall questionnaire which assesses the impact of those symptoms (26 items)

Detailed description

Observational (non-interventional) study with a cross-sectional part for a subset of adult subjects with a single IGQ completion and a longitudinal cross-over part for a subset of subjects with test-retest IGQ completion for validation of electronic version of IGQ. 300 eligible subjects (100 in each of the 3 countries: France, UK \& Spain): * 180 with IBS diagnosis (60% of recruited subjects) * 120 from General population (40% of recruited subjects)

Conditions

Interventions

TypeNameDescription
OTHERcompletion of self-reported questionnairesSingle completion: Participants will have to complete the IGQ, the generic health status EQ-5D questionnaire, the specific FDDQL questionnaire (Functional Digestive Disorders Quality of Life). Test-retest: during the second completion within a mean 7-day interval, participants will complete the IGQ and a single global Gastro-Intestinal Well-Being scale

Timeline

Start date
2017-02-10
Primary completion
2018-04-30
Completion
2018-07-10
First posted
2016-12-26
Last updated
2019-02-18

Locations

5 sites across 3 countries: France, Spain, United Kingdom

Source: ClinicalTrials.gov record NCT03002584. Inclusion in this directory is not an endorsement.